KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Accumulated Expenses (2016 - 2026)

Boston Scientific's Accumulated Expenses history spans 18 years, with the latest figure at $2.5 billion for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 6.8% to $2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.5 billion, a 6.8% increase, with the full-year FY2025 number at $3.2 billion, up 15.43% from a year prior.
  • Accumulated Expenses hit $2.5 billion in Q1 2026 for Boston Scientific, down from $3.2 billion in the prior quarter.
  • Over the last five years, Accumulated Expenses for BSX hit a ceiling of $3.2 billion in Q4 2025 and a floor of $1.9 billion in Q1 2023.
  • Historically, Accumulated Expenses has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2024.
  • Biggest five-year swings in Accumulated Expenses: dropped 18.36% in 2022 and later rose 22.5% in 2023.
  • Tracing BSX's Accumulated Expenses over 5 years: stood at $2.2 billion in 2022, then grew by 22.5% to $2.6 billion in 2023, then grew by 4.8% to $2.8 billion in 2024, then grew by 15.43% to $3.2 billion in 2025, then dropped by 21.46% to $2.5 billion in 2026.
  • Business Quant data shows Accumulated Expenses for BSX at $2.5 billion in Q1 2026, $3.2 billion in Q4 2025, and $3.0 billion in Q3 2025.